Abdulsamet ERDEN,
Berkan ARMAĞAN,
Yusuf Ziya SENER,
Sedat KİRAZ,
Alper SARI,
Ömer KARADAĞ,
Serdar CEYLAN,
Benazir HYMABACCUS,
Levent KILIÇ,
Antonis FANOURIAKIS,
Fatih GÜRLER,
Emre BİLGİN,
Dimitrious T. BOUMPAS
3520
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data
Background/aim: Neonatal lupus erythematosus (NLE) is an autoimmune syndrome caused by transplacental transmission of maternalautoantibodies, often with devastating consequences. The objective of this systematic literature review was to analyze the demographicdata, geoepidemiology, clinical, and serological characteristics associated with NLE.Materials and methods: We performed a systematic literature search of the Pubmed database covering the period from 1976 to August2015, using the MeSH terms “neonatal lupus” or “congenital heart block”. To be included in the study, articles of any type (originalarticles, case series, and case reports) had to report on infants with NLE on an individualized (i.e. patient-by-patient) basis.Results: A total of 198 studies were included in the review, reporting on a total of 755 NLE patients. The most frequently reportedclinical manifestations of NLE were congenital heart block (CHB, 65.2%), cutaneous lupus (33.1%), and cytopenias (15.5%). We founddifferences in NLE characteristics based on study geographical origin, with CHB being much more frequent in patients of European orAmerican descent (49.4% and 35%, respectively), while reports originating from Asia reported a higher prevalence of skin involvement(45.2%). Most CHB cases (72.9%) were diagnosed between the 18th and 26th week of gestation.Conclusions: Phenotypic differences of NLE depending on race and country may reflect true pathophysiologic differences ormethodologic discrepancies. While maternal autoimmune disease is not a prerequisite for the development of NLE, the existence of atruly “immunonegative” CHB is questionable.
___
- 1. Kurosaki K, Miyazaki A, Watanabe K, Echigo S. Long-term
outcome of isolated congenital complete atrioventricular block
pacing since neonatal period: experience at a single Japanese
institution. Circulation Journal 2008; Official Journal of the
Japanese Circulation Society 72 (1): 81-87
- 2. Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD
et al. Neonatal systemic lupus erythematosus syndrome: a
comprehensive review. Clinical Reviews in Allergy & Immunology
2017; 53 (3): 469-476. doi:10.1007/s12016-017-8653-0
- 3. Frankovich J, Sandborg C, Barnes P, Hintz S, Chakravarty E.
Neonatal lupus and related autoimmune disorders of infants.
NeoReviews 2008; 9 (5): e206-e217. doi:10.1542/neo.9-5-e206
- 4. Jayaprasad N, Johnson F, Venugopal K. Congenital complete
heart block and maternal connective tissue disease. International
Journal of Cardiology 2006; 112 (2): 153-158. doi:10.1016/j.
ijcard.2005.11.115
- 5. Sonesson SE, Ambrosi A, Wahren-Herlenius M. Benefits of
fetal echocardiographic surveillance in pregnancies at risk of
congenital heart block: single-center study of 212 anti-Ro52-
positive pregnancies. Ultrasound in Obstetrics & Gynecology
2019; 54 (1): 87-95. doi:10.1002/uog.20214
- 6. Lee LA. The clinical spectrum of neonatal lupus. Archives of
Dermatological Research 2009; 301 (1): 107-110. doi:10.1007/
s00403-008-0896-4
- 7. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM et al. Long-term
outcome of mothers of children with complete congenital heart
block. American Journal of Medicine 1996; 100 (3): 328-332.
doi:10.1016/S0002-9343(97)89492-2
- 8. Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson
S et al. Antibodies to amino acid 200-239 (p200) of Ro52 as
serological markers for the risk of developing congenital heart
block. Clinical and Experimental Immunology 2008; 154 (1):
30-37. doi:10.1111/j.1365-2249.2008.03732.x
- 9. Moretti D, Cimaz R, Vannucci G, Marino A, De Martino M et
al. Cutaneous neonatal lupus: a case report and review of the
literature. International Journal of Dermatology 2014; 53 (12):
1508-1512. doi:10.1111/j.1365-4632.2012.05809.x
- 10. Levesque K, Morel N, Maltret A, Baron G, Masseau A et al.
Description of 214 cases of autoimmune congenital heart
block: Results of the French neonatal lupus syndrome.
Autoimmunity Reviews 2015; 14 (12): 1154-1160. doi:10.1016/j.
autrev.2015.08.005
- 11. Ho A, Gordon P, Rosenthal E, Simpson J, Miller O et al.
Isolated complete heart block in the Fetus. American
Journal of Cardiology 2015; 116 (1): 142-147. doi:10.1016/j.
amjcard.2015.03.051
- 12. Kobayashi R, Mii S, Nakano T, Harada H, Eto H. Neonatal
lupus erythematosus in Japan: a review of the literature.
Autoimmunity Reviews 2009; 8 (6): 462-466. doi:10.1016/j.
autrev.2008.12.013
- 13. Li YQ, Wang Q, Luo Y, Zhao Y. Neonatal lupus erythematosus:
a review of 123 cases in China. International Journal of
Rheumatic Diseases 2015; 18 (7): 761-767. doi:10.1111/1756-
185x.12652
- 14. Izmirly PM, Halushka MK, Rosenberg AZ, Whelton S, Rais-
Bahrami K et al. Clinical and pathologic implications of
extending the spectrum of maternal autoantibodies reactive
with ribonucleoproteins associated with cutaneous and now
cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.
Autoimmunity Reviews 2017; 16 (9): 980-983. doi:10.1016/j.
autrev.2017.07.013
- 15. Brito-Zeron P, Izmirly PM, Ramos-Casals M, Buyon JP,
Khamashta MA. The clinical spectrum of autoimmune
congenital heart block. Nature Reviews Rheumatology 2015;
11 (5): 301-312. doi:10.1038/nrrheum.2015.29
- 16. Zuppa AA, Riccardi R, Frezza S, Gallini F, Luciano RM et
al. Neonatal lupus: follow-up in infants with anti-SSA/Ro
antibodies and review of the literature. Autoimmunity Reviews
2017; 16 (4): 427-432. doi:10.1016/j.autrev.2017.02.010
- 17. Julkunen H, Eronen M. Long-term outcome of mothers
of children with isolated heart block in Finland. Arthritis
& Rheumatology 2001; 44 (3): 647-652. doi:10.1002/1529-
0131(200103)44:3<647::AID-ANR113>3.0.CO;2-I
- 18. Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM
et al. Recurrence rates of cardiac manifestations associated
with neonatal lupus and maternal/fetal risk factors. Arthritis
Rheumatology 2009; 60 (10): 3091-3097. doi:10.1002/art.24768
- 19. Ambrosi A, Salomonsson S, Eliasson H, Zeffer E, Skog A
et al. Development of heart block in children of SSA/SSBautoantibody-
positive women is associated with maternal
age and displays a season-of-birth pattern. Annals of the
Rheumatic Diseases 2012; 71 (3): 334-340. doi:10.1136/
annrheumdis-2011-200207